Clinical Trial Update: A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Fosmanogepix for invasive mold infections is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Mold Infections

Drugs mentioned

• fosmanogepix (fosmanogepix)

Snippet

Sponsor: Basilea Pharmaceutica | Conditions: Invasive Mold Infections | Phase 3 | Status: RECRUITING